| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 136 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 132 |
| 2 | TACROLIMUS OINTMENT 0.1% | 132 |
| 3 | PREDNISONE | 106 |
| 4 | MYCOPHENOLATE MOFETIL | 103 |
| 5 | DEXAMETHASONE | 75 |
| 6 | DEXAMETHASONE 1.5 MG | 75 |
| 7 | PREDNISOLONE | 73 |
| 8 | PREDNISOLONE ORAL | 73 |
| 9 | PREDNISOLONE ORAL SOLUTION | 73 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 31 | 0.0888 |
| 1 | CHLORAMBUCIL | 48 | 0.0122 |
| 2 | HYDRALAZINE HYDROCHLORIDE | 27 | 0.0101 |
| 3 | CLINDAMYCIN PALMITATE HYDROCHLORIDE | 2 | 0.0088 |
| 4 | ANTIBACTERIAL HAND WIPES | 2 | 0.0060 |
| 5 | BENZALKONIUM CHLORIDE 0.13% | 2 | 0.0053 |
| 6 | BENZALKONIUM CHLORIDE | 2 | 0.0046 |
| 7 | ALBENDAZOLE | 8 | 0.0042 |
| 8 | ALEMTUZUMAB | 64 | 0.0033 |
| 9 | POSACONAZOLE | 50 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 254 |
| 1 | Kinase Inhibitor [EPC] | 94 |
| 2 | Azole Antifungal [EPC] | 82 |
| 3 | Alkylating Drug [EPC] | 77 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 64 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 61 |
| 6 | mTOR Inhibitor Immunosuppressant [EPC] | 39 |
| 7 | Insulin Analog [EPC] | 38 |
| 8 | Loop Diuretic [EPC] | 38 |
| 9 | Interleukin-2 Receptor Blocking Antibody [EPC] | 37 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 64 | 0.0033 |
| 1 | Antiprotozoal [EPC] | 31 | 0.0029 |
| 2 | Anthelmintic [EPC] | 8 | 0.0028 |
| 3 | Vitamin D3 Analog [EPC] | 37 | 0.0018 |
| 4 | Rifamycin Antimycobacterial [EPC] | 4 | 0.0011 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 18 | 0.0008 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 17 | 0.0008 |
| 7 | Azole Antifungal [EPC] | 82 | 0.0005 |
| 8 | Sulfonamide Antibacterial [EPC] | 2 | 0.0005 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |